The Swiss pharmaceutical group, Novartis, has posted record-breaking net profits of SFr1.79 billion ($1.1 billion) for the first quarter, a 20 per cent rise on the previous year.This content was published on April 18, 2002 - 08:28
According to a company statement, revenue also increased by 10 per cent, to SFr7.8 billon, compared to SFr7.22 for the same period last year.
swissinfo with agencies
This article was automatically imported from our old content management system. If you see any display errors, please let us know: firstname.lastname@example.org